Hebrew SeniorLife Institute for Aging Research, Boston, Massachusetts2Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Department of Pediatrics, University of Washington and Children's Core for Biomedical Statistics, Seattle Children's Research Institute, Seattle.
JAMA Intern Med. 2014 Oct;174(10):1660-7. doi: 10.1001/jamainternmed.2014.3918.
Infection management in advanced dementia has important implications for (1) providing high-quality care to patients near the end of life and (2) minimizing the public health threat posed by the emergence of multidrug-resistant organisms (MDROs).
DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study of 362 residents with advanced dementia and their health care proxies in 35 Boston area nursing homes for up to 12 months.
Data were collected to characterize suspected infections, use of antimicrobial agents (antimicrobials), clinician counseling of proxies about antimicrobials, proxy preference for the goals of care, and colonization with MDROs (methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and multidrug-resistant gram-negative bacteria). Main outcomes were (1) proportion of suspected infections treated with antimicrobials that met minimum clinical criteria to initiate antimicrobial treatment based on consensus guidelines and (2) cumulative incidence of MDRO acquisition among noncolonized residents at baseline.
The cohort experienced 496 suspected infections; 72.4% were treated with antimicrobials, most commonly quinolones (39.8%) and third- or fourth-generation cephalosporins (20.6%). At baseline, 94.8% of proxies stated that comfort was the primary goal of care, and 37.8% received counseling from clinicians about antimicrobial use. Minimum clinical criteria supporting antimicrobial treatment initiation were present for 44.0% of treated episodes and were more likely when proxies were counseled about antimicrobial use (adjusted odds ratio, 1.42; 95% CI, 1.08-1.86) and when the infection source was not the urinary tract (referent). Among noncolonized residents at baseline, the cumulative incidence of MDRO acquisition at 1 year was 48%. Acquisition was associated with exposure (>1 day) to quinolones (adjusted hazard ratio [AHR], 1.89; 95% CI, 1.28-2.81) and third- or fourth-generation cephalosporins (AHR, 1.57; 95% CI, 1.04-2.40).
Antimicrobials are prescribed for most suspected infections in advanced dementia but often in the absence of minimum clinical criteria to support their use. Colonization with MDROs is extensive in nursing homes and is associated with exposure to quinolones and third- and fourth-generation cephalosporins. A more judicious approach to infection management may reduce unnecessary treatment in these frail patients, who most often have comfort as their primary goal of care, and the public health threat of MDRO emergence.
在晚期痴呆症患者的感染管理中,这对(1)为生命末期的患者提供高质量的护理,以及(2)最大限度地减少由多药耐药菌(MDRO)出现带来的公共卫生威胁,都有着重要的意义。
设计、地点和参与者:这是一项前瞻性队列研究,纳入了 35 家波士顿地区护理院中的 362 名患有晚期痴呆症的患者及其医疗保健代理人,研究时间最长达 12 个月。
研究收集了疑似感染、使用抗菌药物(抗生素)、临床医生就抗生素使用问题对代理人进行咨询、代理人对护理目标的偏好,以及 MDRO(耐甲氧西林金黄色葡萄球菌、万古霉素耐药肠球菌和多药耐药革兰氏阴性菌)定植的数据。主要结局是(1)根据共识指南,根据最低临床标准启动抗生素治疗的疑似感染治疗比例,以及(2)基线时无 MDRO 定植的居民中 MDRO 获得的累积发生率。
该队列共经历了 496 例疑似感染;72.4%的患者接受了抗生素治疗,最常见的是喹诺酮类(39.8%)和第三代或第四代头孢菌素(20.6%)。基线时,94.8%的代理人表示舒适是护理的主要目标,37.8%的代理人接受了关于抗生素使用的临床医生咨询。接受治疗的感染中有 44.0%存在支持抗生素治疗启动的最低临床标准,而当代理人接受抗生素使用咨询(调整后的优势比,1.42;95%置信区间,1.08-1.86)和感染源不是尿路时,这一比例更有可能增加(参照)。在基线时无 MDRO 定植的居民中,1 年内 MDRO 获得的累积发生率为 48%。获得 MDRO 与暴露于喹诺酮类药物(调整后的危害比[HR],1.89;95%置信区间,1.28-2.81)和第三代或第四代头孢菌素(调整后的 HR,1.57;95%置信区间,1.04-2.40)有关。
在晚期痴呆症患者中,大多数疑似感染都开具了抗生素治疗,但通常缺乏支持其使用的最低临床标准。护理院中 MDRO 定植广泛,与接触喹诺酮类药物和第三代或第四代头孢菌素有关。在这些体弱的患者中,采用更谨慎的感染管理方法可能会减少不必要的治疗,这些患者的主要护理目标通常是舒适,而 MDRO 的出现也会带来公共卫生威胁。